SavedAdd your journal

Journals / Türk Serebrovasküler Hastalıklar Dergisi / 2003 / Cilt: 9 - Sayı: 3

Essential thrombocytemia and transient ischemic attack: Case report

Esansiyel trombositozis ve geçici iskemik atak: 2 olgu sunumu

Nefati KIYLIOĞLU
Ali AKYOL
Gürhan KADIKÖYLÜ
Zahit BOLAMAN
Pages
103–105
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, we presented two patient with ET suffered from transient ischémie attack and discussed relation of ET and cerbrovascular disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Essential thrombocytemia (ET) is clonal myeloproliferative disorders such as polycytemia vera, chronic myelogenous leukemia, and idiopathic myelofibrosis.
📊
Key Findings & Data:It is characterized by thrombocytosis, thromboembolic events and mucocutaneous hemorrhage.
💡
Conclusion & Impact:In this paper, we presented two patient with ET suffered from transient ischémie attack and discussed relation of ET and cerbrovascular disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Erkek · Orta yaşlı · Miyeloproliferatif bozukluklar

Abstract

Essential thrombocytemia (ET) is clonal myeloproliferative disorders such as polycytemia vera, chronic myelogenous leukemia, and idiopathic myelofibrosis. It is characterized by thrombocytosis, thromboembolic events and mucocutaneous hemorrhage. Neurological symptoms include headache, vertigo, paresthesia, stroke, dysarthria, scintillating scotomas, syncope and even seizures. In this paper, we presented two patient with ET suffered from transient ischémie attack and discussed relation of ET and cerbrovascular disease.

Özet

Esansiyel trombositoz (ET) polisitemia vera, kronik miyelojen lösemi, idiyopatik miyelofibrozis gibi miyeleoproliferatif bir hastalıktır. Trombositoz, tromboembolik durumlar ve mukokutanöz hemorajiler ile karakterizedir. Nörolojik semptomlar arasında baş ağrısı, baş dönmesi, parestezi, strok, dizartri, skotomlar, senkop ve nöbet görülebilir. Bu yazıda geçici iskemik atak ile gelen 2 olguda ET saptanmış ve ET + serebrovasküler hastalık ilişkisi tartışılmıştır.

🔖

Cite This Article

KIYLIOĞLU, N., AKYOL, A., KADIKÖYLÜ, G., BOLAMAN, Z. (2003). Essential thrombocytemia and transient ischemic attack: Case report. Türk Serebrovasküler Hastalıklar Dergisi, Cilt: 9 - Sayı: 3, 103–105. https://ajindex.com/articles/357832

References (3)

  1. Gunz FW. Hemorrhagic Thrombocytemia: a critical review. Blood I960,15:706-712 2. Lengfelder E, Hochhaus A, Kronawitter U, et al. Should a platelet limit of 600 x 10(9)/L be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages. Br J Haematol 1998,100:15-23. 3. Storen EC, Tefferi A. Long-term use of anagrelide in young patients with essential thrombocytemia. Blood 2001, 97:863-866. 4. Tefferi A, Solberg LA, Silverstein MN. A clinical update in polycythemia vera and essential thrombocytemia. Am J Med 2000,109:141-149. 5. Bolaman Z, Ertop Ş, Yenice N, Canoruç F, Müftüoğlü E., Esansiyel Trombositemia. Dicle Üniversitesi Tıp Fakültesi Dergisi 1990, 3-4:17-22. 6. Sagripanti A, Ferretti A, Nicolini A, Carpi A. Trombotic and hemorrhagic complications in chronic myeloproliferative disorders. Biomed Pharmacother 1996, 50:376-82. 7. Buss DH, Stuart JJ, Lipscomb GE. The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: An analysis of 129 cases. Am J Hematol 1985
  2. Cortelazzo S, Viero P, Finazzi G, et al. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 1990
  3. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988,19:1083-1092. 10. Randi ML, Stocco F, Rossi C, Tison T, Girolami A. Thrombosis and hemorrhage in thrombocytosis: Evaluation of a large cohort of patients (357 cases). J Med 1991, 22:213-217. 11. Arboix A, Besses C, Acin P, Massons JB. Florensa L, Oliveres M, Sabrafen JS. Ischemic Stroke as First Manifestation of Essential Thrombocythemia. Stroke 1995,26:1463-1466. 12. Casto L, Camerlingo M, Finazzi G, Censori B, Barbui T, Mamoli A. Essential thrombocytemia and ischemic stroke: report of six cases. Ital J Neurol Sci 1994,15:359-62 13. Akins PT, Glenn S, Nemeth M, Derdeyn C P. Carotid Artery Thrombus Associated With Severe Iron-Deficiency Anemia and Thrombocytosis. Stroke 1996, 27:1002-1005. 14. Hoffman R. Primary Thrombocytemia. In: Ronald Hoffman, Edward J Benz, Sanford J Shattil eds. Hematology, Basic Principles and Practise 3rd edition. Philadelphia. Churchill Livingstone 2001,1188-1204 15. Ruggeri M, Finazzi G, Tosetto A, et al. No treatment for low- risk thrombocythemia: Results from a prospective study. Br J Haematol 1998,103:772-777.